The accurate determination of the risk of cancer recurrence is a critical unmet need in
managing thyroid cancer (TC). Although numerous studies have successfully demonstrated …

BACKGROUND: Cervical lymph node metastases (LNM) in papillary thyroid carcinomas
(PTCs) are common and develop in approximately 30–80% of PTCs. The presence of …

The present study aimed to systematically examine the molecular mechanisms of papillary
thyroid cancer (PTC), and identify potential biomarkers and drugs for the treatment of PTC …

Background. Papillary thyroid carcinoma (PTC) is a common endocrine malignant
neoplasm, and its incidence increases continuously worldwide in the recent years. However …

Background Thyroid carcinoma (THCA), the most common endocrine neoplasm, typically
exhibits an indolent behavior. However, in some instances, lymph node metastasis (LNM) …

Background Thyroid cancer is the most common endocrine malignancy. However, the
molecular mechanism involved in its pathogenesis is not well characterized. Purpose The …

The aim of the present study was to identify potential therapeutic targets for papillary thyroid
carcinoma (PTC) and to investigate the possible mechanism underlying this disease. The …

Background Although most papillary thyroid carcinoma (PTC) cases have a good prognosis,
some PTCs are more aggressive and are often accompanied by lymph node (LN) …

The molecular mechanism of the occurrence and development of papillary thyroid
carcinoma (PTC) has been widely explored, but has not been completely elucidated. The …

Background The morbidity of thyroid carcinoma has been rising worldwide and increasing
faster than any other cancer type. The most common subtype with the best prognosis is …